Filing Details

Accession Number:
0001209191-17-067630
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-12-29 16:14:10
Reporting Period:
2017-12-27
Accepted Time:
2017-12-29 16:14:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1180262 Herbalife Ltd. HLF Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1713357 Thomas Harms 800 W. Olympic Blvd., Suite 406
Los Angeles CA 90015
Svp, China & Apac No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-12-27 1,000 $21.57 1,000 No 4 M Direct
Common Stock Disposition 2017-12-27 309 $70.00 691 No 4 D Direct
Common Stock Disposition 2017-12-27 261 $70.00 430 No 4 F Direct
Common Stock Acquisiton 2017-12-27 15,000 $6.82 15,430 No 4 M Direct
Common Stock Disposition 2017-12-27 1,462 $70.00 13,968 No 4 D Direct
Common Stock Disposition 2017-12-27 5,436 $70.00 8,532 No 4 F Direct
Common Stock Disposition 2017-12-29 8,532 $68.49 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 D Direct
No 4 F Direct
No 4 M Direct
No 4 D Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Appreciation Right Disposition 2017-12-27 1,000 $0.00 1,000 $21.57
Common Stock Stock Appreciation Right Disposition 2017-12-27 15,000 $0.00 15,000 $6.82
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2011-02-28 2018-02-28 No 4 M Direct
0 2014-02-27 2019-02-27 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 25, 2017.
  2. The reporting person received 430 shares of common stock upon the net exercise of 1,000 stock appreciation rights ("SARs"). The reporting person forfeited 309 shares of common stock underlying such SARs in payment of the exercise price and 261 shares of common stock underlying such SARs to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on December 27, 2017 of $70.00.
  3. The reporting person received 8,102 shares of common stock upon the net exercise of 15,000 SARs. The reporting person forfeited 1,462 shares of common stock underlying such SARs in payment of the exercise price and 5,436 shares of common stock underlying such SARs to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on December 27, 2017 of $70.00.